Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1600"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label | |
| rdf:type | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose | |
| ?:Evidence_type | |
| ?:Evidence_value |
"3.85"
|
| ?:content |
"NOTE: The AUC_i/AUC value is the value for the AUC_0-12 of the S-venlafaxine enantiomer for EMs and is calculated from Table 2. For the R-venlafaxine enantiomer for EMs, the AUC_i/AUC value is 12.18 and is calculated from Table 3. The values for PMs are not significant.
route of administration: oral
study duration: 2 days (twice, a week apart)
population: 12 volunteers
tested for known CYP450 polymorphisms?
YES -- CYP2D6 phenotyping and genotyping -- 7 EMs (3 *1/*4, 4 *1/*1), 5 PMs (1 *3/*4, 4 *4/*4)
ages: 22-37"
|
| dc:creator | |
| dc:date |
"12/11/2012 14:08:15"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ quinidine_increases_auc_venlafaxine, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1638 }